This activity is supported by educational grants from Pharmacyclics LLC. An Abvie Company; Jannsen Biotech, Inc; and Cure Media Group 

FACULTY
Jolynn K. Sessions, PharmD, BCOP
Associate Professor of Clinical Education
UNC Eshelman School of Pharmacy Oncology Clinical Pharmacist
SECU Mission Cancer Center Asheville, North Carolina

EDUCATIONAL OBJECTIVES
At the completion of this activity, the participant will be able to:
  • Explain the recommendations of the place in therapy for new and emerging CLL treatment options
  • Illustrate the management of relapsed and refractory CLL
  • Examine the management of adverse events and complications of novel therapies
  • Demonstrate how to implement strategies that improve communication, patient engagement, education, and decision making with patients with CLL and their health care providers
TARGET AUDIENCE: Clinical and specialty pharmacists 
ACTIVITY TYPE: Application
RELEASE DATE: April 25, 2018
EXPIRATION DATE: May 25, 2019
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This lesson is offered for free at www.pharmacytimes.org.